New influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu): unexpected serious reactions.
Macdonald
L
L
D000081:Acetamides / Q000009:adverse effects*; D058186:Acute Kidney Injury / Q000139:chemically induced; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects*; D002170:Canada; D002648:Child; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006146:Guanidines; D006801:Humans; D008297:Male; D008875:Middle Aged; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D011714:Pyrans; D012140:Respiratory Tract Diseases / Q000139:chemically induced; D012794:Sialic Acids / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir